PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-06-15	12.05 NT$	-0.82%	314,006
26-06-15	12.15 NT$	-1.22%	288,784
26-06-12	12.30 NT$	+0.82%	188,922
26-06-11	12.20 NT$	-0.41%	226,746
26-06-10	12.25 NT$	-1.21%	229,100

End-of-day quote Taiwan S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Taiwan S.E. Other stock markets 2026-06-16			5-day change	1st Jan Change
12.05 ^TWD	-0.82%		-2.03%	-10.74%

06-03	PhytoHealth's Revenue Rises 18% in May	MT
05-11	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	2.39B 75.88M 65.4M 60.22M 56.54M 106M 7.17B 107M 712M 277M 3.51B 285M 279M 12.18B	P/E Ratio 2024	-45.4x	P/E Ratio 2025	-46.1x
Enterprise Value	1.34B 42.62M 36.73M 33.83M 31.76M 59.63M 4.03B 60.26M 400M 156M 1.97B 160M 157M 6.84B	EV / Sales 2024	14.8x	EV / Sales 2025	12.1x
Free-Float	75.64%	Yield 2024 *	-	Yield 2025	-

06-03	PhytoHealth's Revenue Rises 18% in May	MT
05-11	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-10	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-09-21	PhytoHealth Corporation(TWSE:4108) dropped from S&P Global BMI Index	CI
25-08-13	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-06	PhytoHealth, German Firm to Jointly Market Rectal Pain Drug in EU	MT
25-05-04	PhytoHealth Corporation Signs Letter of Intent with Aristo Pharma GmbH	CI
25-05-04	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-03-06	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Member of Audit Committee and Remuneration Committee	CI
25-03-06	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Independent Director	CI
25-02-27	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-11-11	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

22-08-09	PhytoHealth : BOD approve the 2022 second quarter consolidated financial report	PU
22-07-05	Phytohealth : is invited to Online Investor Conference held by KGI Securities	PU
22-05-24	PhytoHealth : Important resolutions of company's 2022 shareholders' meeting.	PU
22-04-08	PhytoHealth : Public announcement of the progress of company's committed items at the time when stock was listed on Taiwan Stock Exchange.	PU
22-03-09	PhytoHealth : Announcement of the financial information of February 2022	PU

PhytoHealth Corporation Stock

Stocks

4108

TW0004108006

Pharmaceuticals

Valuation: PhytoHealth Corporation

Chart: PhytoHealth Corporation

Latest news : PhytoHealth Corporation

Press Releases: PhytoHealth Corporation

Quotes and Performance

Course Extremes

Managers and Directors: PhytoHealth Corporation

Biopharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	-0.82%
1 week	-2.03%
Current month	-2.82%
1 month	+2.99%
3 months	-10.41%
6 months	-13.31%
Current year	-10.74%

1 week	12	12.45
1 month	11.4	13.15
Current year	11.4	15.25
1 year	11.4	17.9
3 years	11	25.25
5 years	11	25.25
10 years	10.25	41.05

Manager	Title	Age	Since
I Lin Lee CEO	Chief Executive Officer	-	2017-06-12
Chih Yuan Huang DFI	Director of Finance/CFO	-	2021-05-10
Teng Hsu Wang CTO	Chief Tech/Sci/R&D Officer	-	2021-07-29

Director	Title	Age	Since
Ching Chung Tsai BRD	Director/Board Member	-	2014-06-11
Yue Ju Lai BRD	Director/Board Member	-	2010-03-15
Yi Li Lee CHM	Chairman	55	2020-05-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PHYTOHEALTH CORPORATION	-0.82%	-2.03%	-18.03%	-44.98%	76.49M
REGENERON PHARMACEUTICALS, INC.	-0.01%	-0.13%	+17.74%	-21.41%	62.57B
UCB	-3.55%	-4.69%	+54.37%	+191.44%	57.25B
SAMSUNG BIOLOGICS CO.,LTD.	+0.08%	+33.30%	+33.30%	+33.30%	40.76B
CSL LIMITED	+0.68%	+8.52%	-55.52%	-61.99%	36.28B
BIOGEN INC.	-1.48%	-1.52%	+49.63%	-34.09%	29.33B
MODERNA, INC.	+8.80%	+19.04%	+118.54%	-55.86%	20.68B
INCYTE CORPORATION	-2.05%	-3.42%	+39.99%	+57.68%	20.37B
INNOVENT BIOLOGICS, INC.	-1.29%	+4.30%	-5.33%	+125.04%	17.17B
SWEDISH ORPHAN BIOVITRUM AB	-1.06%	-1.24%	+49.13%	+90.61%	16.04B
Average	-0.10%	+3.11%	+28.38%	+27.97%	30.05B
Weighted average by Cap.	-0.41%	+2.88%	+29.89%	+37.75%

	2024	2025
Net sales	154M 4.87M 4.2M 3.86M 3.63M 6.81M 460M 6.88M 45.66M 17.79M 225M 18.27M 17.88M 781M	135M 4.27M 3.68M 3.39M 3.18M 5.97M 403M 6.03M 40.01M 15.59M 198M 16.01M 15.67M 685M
Net income	-73.5M -2.33M -2.01M -1.85M -1.74M -3.26M -220M -3.29M -21.85M -8.51M -108M -8.75M -8.56M -374M	-58.2M -1.85M -1.59M -1.46M -1.37M -2.58M -174M -2.61M -17.3M -6.74M -85.43M -6.93M -6.78M -296M
Net Debt	-1.06B -33.67M -29.01M -26.72M -25.09M -47.1M -3.18B -47.6M -316M -123M -1.56B -126M -124M -5.4B	-1.05B -33.26M -28.66M -26.39M -24.78M -46.53M -3.14B -47.02M -312M -122M -1.54B -125M -122M -5.34B